Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction

William Y. Ho, Joseph N. Blattman, Michelle L. Dossett, Cassian Yee, Philip D. Greenberg

Research output: Contribution to journalReview article

119 Scopus citations

Abstract

Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.

Original languageEnglish (US)
Pages (from-to)431-437
Number of pages7
JournalCancer cell
Volume3
Issue number5
DOIs
StatePublished - May 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction'. Together they form a unique fingerprint.

  • Cite this